Manning & Napier Advisors LLC Takes $3.29 Million Position in Colgate-Palmolive (NYSE:CL)

Manning & Napier Advisors LLC bought a new stake in shares of Colgate-Palmolive (NYSE:CLFree Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 36,226 shares of the company’s stock, valued at approximately $3,293,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive in the third quarter worth $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive in the 3rd quarter valued at $53,000. Prospera Private Wealth LLC purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $64,000. Finally, True Wealth Design LLC raised its stake in shares of Colgate-Palmolive by 1,460.9% during the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after purchasing an additional 672 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on CL shares. UBS Group decreased their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a report on Thursday, January 16th. JPMorgan Chase & Co. decreased their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research note on Thursday, January 16th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company dropped their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $102.00.

View Our Latest Report on CL

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Trading Down 0.2 %

Shares of CL stock opened at $89.65 on Thursday. Colgate-Palmolive has a 52-week low of $82.68 and a 52-week high of $109.30. The business’s fifty day moving average is $91.67 and its 200 day moving average is $97.34. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The company has a market capitalization of $73.24 billion, a PE ratio of 25.69, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.23%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.